The Best Choice: HHS Lead On Drug Price Reform Brings Expertise In Part D Contracting
Appointment of CVS Health executive Daniel Best could help Centers for Medicare and Medicaid Services address some pharmacy benefit manager concerns with point-of-sale rebates in Part D.
You may also be interested in...
Recent developments in US federal government regulation of prescription drug pricing and reimbursement.
No big policy implementation expected to be announced during president's speech planned for next week. HHS will continue to gather feedback on various approaches to lowering drug pricing.
Biggest benefit to manufacturers from the insurer's upcoming program may be relieving public pressure on list prices.